Section | Title | Authors | Address |
---|
|
Genes | ABCB5 (ATP-binding cassette, sub-family B (MDR/TAP), member 5) | Jiao X, Sjöblom T | http://atlasgeneticsoncology.org/Genes/ABCB5ID44305ch7p15.html |
Genes | ADAM9 (ADAM metallopeptidase domain 9 (meltrin gamma)) | Sung SY | http://atlasgeneticsoncology.org/Genes/ADAM9ID573ch8p11.html |
Genes | ADAMTS1 (ADAM metallopeptidase with thrombospondin type 1 motif, 1) | Rocks N, Cataldo D | http://atlasgeneticsoncology.org/Genes/ADAMTS1ID574ch21q21.html |
Genes | ADIPOR1 (adiponectin receptor 1) | Kaklamani V, Mantzoros C | http://atlasgeneticsoncology.org/Genes/ADIPOR1ID44512ch1q32.html |
Genes | AIFM2 (apoptosis-inducing factor, mitochondrion-associated, 2) | Varecha M | http://atlasgeneticsoncology.org/Genes/AIFM2ID41842ch10q22.html |
Genes | AKT1 (v-akt murine thymoma viral oncogene homolog 1) | Etro D, Missiroli S, Buontempo F, Neri LM, Capitani S | http://atlasgeneticsoncology.org/Genes/AKT1ID355ch14q32.html |
Genes | AMER1 (APC membrane recruitment protein 1) | Ruteshouser EC | http://atlasgeneticsoncology.org/Genes/FAM123BID44119chXq11.html |
Genes | ANLN (anillin, actin binding protein) | Daigo Y, Nakamura Y | http://atlasgeneticsoncology.org/Genes/ANLNID44318ch7p14.html |
Genes | APLNR (apelin receptor) | Audigier Y | http://atlasgeneticsoncology.org/Genes/APLNRID44364ch11q12.html |
Genes | AREG (amphiregulin (schwannoma-derived growth factor)) | Berasain C, Avila MA | http://atlasgeneticsoncology.org/Genes/AREGID690ch4q13.html |
Genes | ASPM (asp (abnormal spindle) homolog, microcephaly associated (Drosophila)) | Peng SY, Lin SY, Hsu HC | http://atlasgeneticsoncology.org/Genes/ASPMID44463ch1q31.html |
Genes | ATF3 (activating transcription factor 3) | Kitajima S, Tanaka Y, Kawauchi J | http://atlasgeneticsoncology.org/Genes/ATF3ID719ch1q32.html |
Genes | ATF4 (activating transcription factor 4 (tax-responsive enhancer element B67)) | Ameri K, Harris AL | http://atlasgeneticsoncology.org/Genes/ATF4ID44413ch22q13.html |
Genes | B3GNT6 (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)) | Sharma NM, Radhakrishnan P, Tan S, Cheng PW | http://atlasgeneticsoncology.org/Genes/B3GNT6ID44427ch11q13.html |
Genes | BAP1 (BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)) | Guénard F, Durocher F | http://atlasgeneticsoncology.org/Genes/BAP1ID755ch3p21.html |
Genes | BAX (BCL2-associated X protein) | Thomadaki H, Scorilas A | http://atlasgeneticsoncology.org/Genes/BAXID128ch19q13.html |
Genes | BCL10 (B-cell CLL/lymphoma 10) | Lin P | http://atlasgeneticsoncology.org/Genes/BCL10ID222ch1p22.html |
Genes | BCL2L1 (BCL2-like 1) | Varna M, Ratajczak P, Bertheau P, Janin A | http://atlasgeneticsoncology.org/Genes/BCL2L1ID129ch20q11.html |
Genes | BIRC2 (baculoviral IAP repeat-containing 2) | Maeshima A, Tsuda H | http://atlasgeneticsoncology.org/Genes/BIRC2ID795ch11q22.html |
Genes | BMI1 (BMI1 polycomb ring finger oncogene) | Han L, Fatrai S, Schuringa JJ | http://atlasgeneticsoncology.org/Genes/BMI1ID807ch10p12.html |
Genes | CAPG (capping protein (actin filament), gelsolin-like) | Singh PK, Tamuli R | http://atlasgeneticsoncology.org/Genes/CAPGID44449ch2p11.html |
Genes | CCNB1 (cyclin B1) | Perez-Stable C | http://atlasgeneticsoncology.org/Genes/CCNB1ID951ch5q13.html |
Genes | CCR9 (chemokine (C-C motif) receptor 9) | Nomiyama H, Yoshie O | http://atlasgeneticsoncology.org/Genes/CCR9ID44380ch3p21.html |
Genes | CD151 (CD151 molecule (Raph blood group)) | Weidenhofer J, Ashman LK | http://atlasgeneticsoncology.org/Genes/CD151ID967ch11p15.html |
Genes | CD44 (CD44 molecule (Indian blood group)) | Sen YP, Yip GW | http://atlasgeneticsoncology.org/Genes/CD44ID980ch11p13.html |
Genes | CD82 (CD82 molecule) | Zhang YH, Richardson MM, Zhang F, Zhang XA | http://atlasgeneticsoncology.org/Genes/CD82ID41045ch11p11.html |
Genes | CD9 (CD9 molecule) | Humbert L, Chevrette M | http://atlasgeneticsoncology.org/Genes/CD9ID995ch12p13.html |
Genes | CDA (Cytidine Deaminase) | Saito Y | http://atlasgeneticsoncology.org/Genes/CDAID998ch1p36.html |
Genes | CDK20 (cell cycle related kinase) | Lin M, Cheung W | http://atlasgeneticsoncology.org/Genes/CCRKID43196ch9q22.html |
Genes | CDT1 (chromatin licensing and DNA replication factor 1) | Deka R, Tamuli R | http://atlasgeneticsoncology.org/Genes/CDT1ID44175ch16q24.html |
Genes | CEACAM1 (carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)) | Matsuda Y | http://atlasgeneticsoncology.org/Genes/CEACAM1ID40044ch19q13.html |
Genes | CITED4 (Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4) | Torres-Martin M, Rey JA | http://atlasgeneticsoncology.org/Genes/CITED4ID44535ch1p34.html |
Genes | CKS1B (CDC28 protein kinase regulatory subunit 1B) | Zhang Y | http://atlasgeneticsoncology.org/Genes/CKS1BID40092ch1q21.html |
Genes | CLIC4 (chloride intracellular channel 4) | Padmakumar VC, Yuspa SH | http://atlasgeneticsoncology.org/Genes/CLIC4ID40102ch1p36.html |
Genes | CLU (clusterin) | Rauhala H, Visakorpi T | http://atlasgeneticsoncology.org/Genes/CLUID40107ch8p21.html |
Genes | COL16A1 (collagen, type XVI, alpha 1) | Grässel S, Ratzinger S | http://atlasgeneticsoncology.org/Genes/COL16A1ID44542ch1p35.html |
Genes | COPS2 (COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)) | Jennek S, Kraft F, Baniahmad A | http://atlasgeneticsoncology.org/Genes/COPS2ID47362ch15q21.html |
Genes | CREBBP (CREB binding protein) | Gervasini C | http://atlasgeneticsoncology.org/Genes/CBPID42.html |
Genes | CRYAB (crystallin, alpha B) | Ilhan A, Wagner L, Gartner W | http://atlasgeneticsoncology.org/Genes/CRYABID40156ch11q23.html |
Genes | CST6 (cystatin E/M) | Keppler D | http://atlasgeneticsoncology.org/Genes/CST6ID40178ch11q13.html |
Genes | CTSL (cathepsin L1) | Goulet B, Nepveu A | http://atlasgeneticsoncology.org/Genes/CTSL1ID40208ch9q21.html |
Genes | CYP2A6 (cytochrome P450, family 2, subfamily A, polypeptide 6) | Inui N | http://atlasgeneticsoncology.org/Genes/CYP2A6ID40240ch19q13.html |
Genes | CYP2W1 (cytochrome P450, family 2, subfamily W, polypeptide 1) | Karlgren M | http://atlasgeneticsoncology.org/Genes/CYP2W1ID44337ch7p22.html |
Genes | CYP7B1 (cytochrome P450, family 7, subfamily B, polypeptide 1) | Norlin M | http://atlasgeneticsoncology.org/Genes/CYP7B1ID40255ch8q21.html |
Genes | DAB2 (disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila)) | Orlandini M | http://atlasgeneticsoncology.org/Genes/DAB2ID40258ch5p13.html |
Genes | DAPK1 (death-associated protein kinase 1) | Schneider-Stock R, Roessner A, Bajbouj K | http://atlasgeneticsoncology.org/Genes/DAPK1ID417ch9q21.html |
Genes | DAXX (death-associated protein 6) | Kim E | http://atlasgeneticsoncology.org/Genes/DAXXID40265ch6p21.html |
Genes | DHX9 (DEAH (Asp-Glu-Ala-His) box polypeptide 9) | Guénard F, Durocher F | http://atlasgeneticsoncology.org/Genes/DHX9ID44879ch1q25.html |
Genes | DIRAS3 (DIRAS family, GTP-binding RAS-like 3) | Yu Y, Lu Z, Luo RZ, Bast RC Jr | http://atlasgeneticsoncology.org/Genes/DIRAS3ID702ch1p31.html |
Genes | DLG1 (discs, large homolog 1 (Drosophila)) | Massimi P, Banks L | http://atlasgeneticsoncology.org/Genes/DLG1ID40333ch3q29.html |
Genes | DSG2 (desmoglein 2) | Yashiro M | http://atlasgeneticsoncology.org/Genes/DSG2ID40367ch18q12.html |
Genes | ECM1 (extracellular matrix protein 1) | Merregaert J, Van Hul W | http://atlasgeneticsoncology.org/Genes/ECM1ID40398ch1q21.html |
Genes | EEF1A1 (eukaryotic translation elongation factor 1 alpha 1) | Scaggiante B, Manzini G | http://atlasgeneticsoncology.org/Genes/EEF1A1ID40407ch6q13.html |
Genes | EIF3F (eukaryotic translation initiation factor 3, subunit F) | Shi J, Nelson MA | http://atlasgeneticsoncology.org/Genes/EIF3FID44407ch11p15.html |
Genes | EIF4EBP1 (Eukaryotic translation initiation factor 4E binding protein 1) | Clemens M, Coldwell M | http://atlasgeneticsoncology.org/Genes/EIF4EBP1ID40432ch8p12.html |
Genes | EML4 (echinoderm microtubule associated protein like 4) | Perner S, Wilbertz T, Stiedl AC, Rubin MA | http://atlasgeneticsoncology.org/Genes/EML4ID44353ch2p21.html |
Genes | ENO1 (Enolase 1, (alpha)) | Trojanowicz B, Hoang-Vu C, Sekulla C | http://atlasgeneticsoncology.org/Genes/ENO1ID40453ch1p36.html |
Genes | EPHA3 (EPH receptor A3) | Stringer B, Day B, McCarron J, Lackmann M, Boyd A | http://atlasgeneticsoncology.org/Genes/EPHA3ID40463ch3p11.html |
Genes | ESRRA (estrogen-related receptor alpha) | Stein Kunder R, McDonnell DP | http://atlasgeneticsoncology.org/Genes/ESRRAID44408ch11q13.html |
Genes | ESRRG (estrogen-related receptor gamma) | Riggins RB | http://atlasgeneticsoncology.org/Genes/ESRRGID45840ch1q41.html |
Genes | FAIM (Fas apoptotic inhibitory molecule) | Segura MF, Sole C, Moubarak RS, Yuste VJ, Comella JX | http://atlasgeneticsoncology.org/Genes/FAIMID43251ch3q22.html |
Genes | FHL2 (four and a half LIM domains 2) | Lin M, Cheung W | http://atlasgeneticsoncology.org/Genes/FHL2ID44092ch2q12.html |
Genes | FSTL3 (follistatin-like 3 (secreted glycoprotein)) | Grusch M | http://atlasgeneticsoncology.org/Genes/FSTL3ID111ch19p13.html |
Genes | GADD45GIP1 (growth arrest and DNA-damage-inducible, gamma interacting protein 1) | Nakayama K, Nakayama N, Wang TL | http://atlasgeneticsoncology.org/Genes/GADD45GIP1ID40668ch19p13.html |
Genes | GAS5 (growth arrest-specific 5 (non-protein coding)) | Mourtada-Maarabouni M | http://atlasgeneticsoncology.org/Genes/GAS5ID50217ch1q25.html |
Genes | GATA2 (GATA binding protein 2) | Viguié F | http://atlasgeneticsoncology.org/Genes/GATA2ID44160ch3q21.html |
Genes | GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa) | Britzen-Laurent N, Stürzl M | http://atlasgeneticsoncology.org/Genes/GBP1ID50147ch1p22.html |
Genes | GPER1 (G protein-coupled estrogen receptor 1) | Prossnitz Eric R | http://atlasgeneticsoncology.org/Genes/GPERID44344ch7p22.html |
Genes | GPNMB (glycoprotein (transmembrane) nmb) | Patel SA, Lim PK, Rameshwar P | http://atlasgeneticsoncology.org/Genes/GPNMBID40739ch7p15.html |
Genes | H2AFX (H2A histone family, member X) | Srivastava N, Gochhait S, Kalaiarasan P, Bamezai RNK | http://atlasgeneticsoncology.org/Genes/H2AFXID40783ch11q23.html |
Genes | HAS2 (hyaluronan synthase 2) | Escudero D | http://atlasgeneticsoncology.org/Genes/HAS2ID412ch8q24.html |
Genes | HBP1 (HMG-box transcription factor 1) | Paulson KE, Yee AS | http://atlasgeneticsoncology.org/Genes/HBP1ID40791ch7q22.html |
Genes | HNRNPD (heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)) | Sekulla C, Trojanowicz B, Hoang-Vu C | http://atlasgeneticsoncology.org/Genes/HNRNPDID40840ch4q21.html |
Genes | HNRNPK (heterogeneous nuclear ribonucleoprotein K) | Mikula M, Ostrowski J | http://atlasgeneticsoncology.org/Genes/HNRNPKID44314ch9q21.html |
Genes | HOXC13 (homeobox C13) | Yamada T, Tsuchida S | http://atlasgeneticsoncology.org/Genes/HOXC13ID473ch12q13.html |
Genes | HSPA5 (heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)) | Zimmermann R, Dudek J | http://atlasgeneticsoncology.org/Genes/HSPA5ID40876ch9q33.html |
Genes | HSPB1 (Heat-Shock 27 kDa Protein 1) | Laskowska E, Kuczyńska-Wiśik D, Matuszewska E | http://atlasgeneticsoncology.org/Genes/HSPB1ID40880ch7q11.html |
Genes | HTATIP2 (HIV-1 Tat interactive protein 2, 30kDa) | Zhao J | http://atlasgeneticsoncology.org/Genes/HTATIP2ID40894ch11p15.html |
Genes | IDO1 (indoleamine 2,3-dioxygenase 1) | Chang MY, Muller AJ, Prendergast GC | http://atlasgeneticsoncology.org/Genes/IDO1ID40973ch8p11.html |
Genes | IDO2 (indoleamine 2,3-dioxygenase 2) | Chang MY, Metz R, Muller AJ, Prendergast GC | http://atlasgeneticsoncology.org/Genes/IDO2ID44387ch8p11.html |
Genes | IER3 (immediate early response 3) | Schäfer H, Arlt A | http://atlasgeneticsoncology.org/Genes/IER3ID40919ch6p21.html |
Genes | ING2 (inhibitor of growth family, member 2) | Jennek S, Baniahmad A | http://atlasgeneticsoncology.org/Genes/ING2ID40975ch4q35.html |
Genes | INPPL1 (inositol polyphosphate phosphatase-like 1) | Prasad NK | http://atlasgeneticsoncology.org/Genes/INPPL1ID40984ch11q13.html |
Genes | IRF4 (interferon regulatory factor 4) | Rasi S, Gaidano G | http://atlasgeneticsoncology.org/Genes/IRF4ID231ch6p25.html |
Genes | JAK1 (Janus kinase 1) | Knoops L, Hornakova T, Renauld JC | http://atlasgeneticsoncology.org/Genes/JAK1ID41031ch1p31.html |
Genes | JAZF1 (JAZF zinc finger 1) | Li H, Sklar J | http://atlasgeneticsoncology.org/Genes/JAZF1ID41036ch7p15.html |
Genes | KCMF1 (potassium channel modulatory factor 1) | Mandrawalia R, Tamuli R | http://atlasgeneticsoncology.org/Genes/KCMF1ID46364ch2p11.html |
Genes | KLK4 (kallikrein-related peptidase 4) | Lai J, Dong Y, Clements JA | http://atlasgeneticsoncology.org/Genes/KLK4ID41084ch19q13.html |
Genes | KLK7 (kallikrein-related peptidase 7) | Dong Y, Lai J, Clements JA | http://atlasgeneticsoncology.org/Genes/KLK7ID41087ch19q13.html |
Genes | LIFR (leukemia inhibitory factor receptor alpha) | Dagoneau N, Cormier-Daire V | http://atlasgeneticsoncology.org/Genes/LIFRID410ch5p13.html |
Genes | LIMK1 (LIM domain kinase 1) | Chakrabarti R | http://atlasgeneticsoncology.org/Genes/LIMK1ID41159ch7q11.html |
Genes | LOX (lysyl oxidase) | Fong SFT, Fong KSK, Csiszar K | http://atlasgeneticsoncology.org/Genes/LOXID41191ch5q23.html |
Genes | LOXL2 (lysyl oxidase-like 2) | Fong SFT, Fong KSK, Csiszar K | http://atlasgeneticsoncology.org/Genes/LOXL2ID41192ch8p21.html |
Genes | LPAR1 (lysophosphatidic acid receptor 1) | Murph MM, Radhakrishna H | http://atlasgeneticsoncology.org/Genes/LPAR1ID40405ch9q31.html |
Genes | MAF (v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian)) | Eychö A, Pouponnot C | http://atlasgeneticsoncology.org/Genes/MAFID41234ch16q23.html |
Genes | MAFA (v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian)) | Pouponnot C, Eychö A | http://atlasgeneticsoncology.org/Genes/MAFAID41235ch8q24.html |
Genes | MAP3K7 (mitogen-activated protein kinase kinase kinase 7) | Tang HH, Yeung KC | http://atlasgeneticsoncology.org/Genes/MAP3K7ID454ch6q15.html |
Genes | MAP4 (microtubule-associated protein 4) | Murga Penas EM, Dierlamm J | http://atlasgeneticsoncology.org/Genes/MAP4ID44410ch3p21.html |
Genes | MAPK13 (mitogen-activated protein kinase 13) | Cerezo-Guisado MI, Cuenda A | http://atlasgeneticsoncology.org/Genes/MAPK13ID41291ch6p21.html |
Genes | MBD2 (methyl CpG binding domain protein 2) | Owen H | http://atlasgeneticsoncology.org/Genes/MBD2ID41309ch18q21.html |
Genes | MCPH1 (microcephalin 1) | Liang Y, Lin SY, Li K | http://atlasgeneticsoncology.org/Genes/MCPH1ID44370ch8p23.html |
Genes | MEF2D (myocyte enhancer factor 2D) | Prima V, Glushakova LG, Hunger SP | http://atlasgeneticsoncology.org/Genes/MEF2DID43636ch1q22.html |
Genes | METAP2 (methionyl aminopeptidase 2) | Selvakumar P, Sharma RK | http://atlasgeneticsoncology.org/Genes/METAP2ID46053ch12q22.html |
Genes | MIER1 (mesoderm induction early response 1 homolog (Xenopus laevis)) | Gillespie LL, Paterno GD | http://atlasgeneticsoncology.org/Genes/MIER1ID50389ch1p31.html |
Genes | MUC2 (mucin 2, oligomeric mucus/gel-forming) | Yonezawa S, Yamada N, Yokoyama S, Kitamoto S, Higashi M, Goto M | http://atlasgeneticsoncology.org/Genes/MUC2ID41457ch11p15.html |
Genes | MUC5AC (mucin 5AC, oligomeric mucus/gel-forming) | Mejías-Luque R, Cobler L, de Bolós C | http://atlasgeneticsoncology.org/Genes/MUC5ACID41460ch11p15.html |
Genes | MUC6 (mucin 6, oligomeric mucus/gel-forming) | Cobler L, Garrido M, de Bolós C | http://atlasgeneticsoncology.org/Genes/MUC6ID44115ch11p15.html |
Genes | MYB (v-myb myeloblastosis viral oncogene homolog (avian)) | Zhao L, Pattabiraman DR, Gonda TJ | http://atlasgeneticsoncology.org/Genes/MYBID41466ch6q23.html |
Genes | MYBL1 (v-myb myeloblastosis viral oncogene homolog (avian)-like 1) | Chayka O, Sala A | http://atlasgeneticsoncology.org/Genes/MYBL1ID41468ch8q13.html |
Genes | NAT1 (N-acetyltransferase 1 (arylamine N-acetyltransferase)) | Ruiz JD, Agúndez JAG, Martínez C, García-Martín E | http://atlasgeneticsoncology.org/Genes/NAT1ID41497ch8p22.html |
Genes | NAT2 (N-acetyltransferase 2 (arylamine N-acetyltransferase)) | Ruiz JD, Agúndez JAG, Martínez C, García-Martín E | http://atlasgeneticsoncology.org/Genes/NAT2ID41498ch8p22.html |
Genes | NDRG1 (N-myc downstream regulated 1) | Wissing M, Rosmus N, Carducci M, Kachhap S | http://atlasgeneticsoncology.org/Genes/NDRG1ID41512ch8q24.html |
Genes | NKX3-1 (NK3 homeobox 1) | Song LN, Gelmann EP | http://atlasgeneticsoncology.org/Genes/NKX31ID41541ch8p21.html |
Genes | NNMT (nicotinamide N-methyltransferase) | Emanuelli M, Cecati M, Sartini D, Pozzi V | http://atlasgeneticsoncology.org/Genes/NNMTID44506ch11q23.html |
Genes | NOL3 (nucleolar protein 3 (apoptosis repressor with CARD domain)) | Kung G, McKimpson W, Kitsis RN | http://atlasgeneticsoncology.org/Genes/NOL3ID41552ch16q22.html |
Genes | NPY (neuropeptide Y) | Ruscica M, Dozio E, Magni P | http://atlasgeneticsoncology.org/Genes/NPYID44438ch7p15.html |
Genes | NRCAM (neuronal cell adhesion molecule) | Janik J, Czarnocka B | http://atlasgeneticsoncology.org/Genes/NRCAMID41578ch7q31.html |
Genes | NRIP1 (nuclear receptor interacting protein 1) | Spinella MJ | http://atlasgeneticsoncology.org/Genes/NRIP1ID44067ch21q11.html |
Genes | OPCML (opioid binding protein/cell adhesion molecule-like) | Czekierdowski A, Czekierdowska S | http://atlasgeneticsoncology.org/Genes/OPCMLID44423ch11q25.html |
Genes | ORAOV1 (oral cancer overexpressed 1) | Jiang L, Yu J, Chen Q | http://atlasgeneticsoncology.org/Genes/ORAOV1ID41611ch11q13.html |
Genes | PAX6 (paired box 6) | Zhou YH | http://atlasgeneticsoncology.org/Genes/PAX6ID211ch11p13.html |
Genes | PAX8 (paired box 8) | de Biase D, Morandi L, Tallini G | http://atlasgeneticsoncology.org/Genes/PAX8ID382ch2q13.html |
Genes | PHLPP1 (PH domain leucine-rich repeat protein phosphatase 1) | O'Neill AK, Newton AC | http://atlasgeneticsoncology.org/Genes/PHLPP1ID44544ch18q21.html |
Genes | PHLPP2 (PH domain leucine-rich repeat protein phosphatase 2) | O'Neill AK, Newton AC | http://atlasgeneticsoncology.org/Genes/PHLPP2ID44546ch16q22.html |
Genes | PIK3CA (phosphoinositide-3-kinase, catalytic, alpha polypeptide) | Sanchez-Cespedes M | http://atlasgeneticsoncology.org/Genes/PIK3CAID415ch3q26.html |
Genes | PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent)) | Linkous A, Yazlovitskaya E | http://atlasgeneticsoncology.org/Genes/PLA2G4AID41733ch1q31.html |
Genes | PLAUR (plasminogen activator, urokinase receptor) | Jacobsen B, Illemann M, Ploug M | http://atlasgeneticsoncology.org/Genes/PLAURID41741ch19q13.html |
Genes | PLXNB1 (plexin B1) | Gómez-Román JJ, Nicolas Martínez M, Lazuén Fernández S, Val-Bernal JF | http://atlasgeneticsoncology.org/Genes/PLXNB1ID43413ch3p21.html |
Genes | PPARD (peroxisome proliferator-activated receptor delta) | Astarci E, Banerjee S | http://atlasgeneticsoncology.org/Genes/PPARDID41794ch6p21.html |
Genes | PSCA (Prostate stem cell antigen) | Raff AB, Gray A, Kast WM | http://atlasgeneticsoncology.org/Genes/PSCAID41881ch8q24.html |
Genes | PTGIS (prostaglandin I2 (prostacyclin) synthase) | Cebola I, Peinado MA | http://atlasgeneticsoncology.org/Genes/PTGISID44219ch20q13.html |
Genes | PTMA (prothymosin, alpha) | Tanaka K, Kusunoki M | http://atlasgeneticsoncology.org/Genes/PTMAID44094ch2q37.html |
Genes | PTPA ( protein phosphatase 2 phosphatase activator) | Janssens V | http://atlasgeneticsoncology.org/Genes/PPP2R4ID41817ch9q34.html |
Genes | PTPRD (protein tyrosine phosphatase, receptor type, D) | Parthasarathi L, Stallings RL | http://atlasgeneticsoncology.org/Genes/PTPRDID41927ch9p23.html |
Genes | RAN (RAN, member RAS oncogene family) | Rensen WM, Lavia P | http://atlasgeneticsoncology.org/Genes/RANID42039ch12q24.html |
Genes | RASL11B (RAS-like, family 11, member B) | Lorkowski S | http://atlasgeneticsoncology.org/Genes/RASL11BID44265ch4q12.html |
Genes | RASSF2 (Ras association (RalGDS/AF-6) domain family member 2) | Hesson LB, Latif F | http://atlasgeneticsoncology.org/Genes/RASSF2ID43461ch20p13.html |
Genes | RBBP7 (retinoblastoma binding protein 7) | Sinha N, Tamuli R | http://atlasgeneticsoncology.org/Genes/RBBP7ID42065chXp22.html |
Genes | RLN2 (relaxin 2) | Willcox JM, Summerlee AJS | http://atlasgeneticsoncology.org/Genes/RLN2ID44421ch9p24.html |
Genes | RRM1 (ribonucleotide reductase M1) | Freeman SN, Bepler G | http://atlasgeneticsoncology.org/Genes/RRM1ID42174ch11p15.html |
Genes | RUVBL1 (RuvB-like 1 (E. coli)) | Haurie V, Grigoletto A, Rosenbaum J | http://atlasgeneticsoncology.org/Genes/RUVBL1ID44415ch3q21.html |
Genes | RUVBL2 (RuvB-like 2 (E. coli)) | Grigoletto A, Haurie V, Rosenbaum J | http://atlasgeneticsoncology.org/Genes/RUVBL2ID42185ch19q13.html |
Genes | SATB1 (SATB homeobox 1) | Richards H, Kohwi-Shigematsu T | http://atlasgeneticsoncology.org/Genes/SATB1ID44225ch3p24.html |
Genes | SEMA3B (sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B) | Bhattacharyya M, Tamuli R | http://atlasgeneticsoncology.org/Genes/SEMA3BID42252ch3p21.html |
Genes | SFRP4 (Secreted Frizzled-Related Protein 4) | Carmon KS, Loose DS | http://atlasgeneticsoncology.org/Genes/SFRP4ID42277ch7p14.html |
Genes | SH3GL2 (SH3-domain GRB2-like 2) | Panda CK, Ghosh A, Maiti GP | http://atlasgeneticsoncology.org/Genes/SH3GL2ID44345ch9p22.html |
Genes | SHC1 (SHC (Src homology 2 domain containing) transforming protein 1) | Luzi L, Migliaccio E, Pelicci PG | http://atlasgeneticsoncology.org/Genes/SHC1ID42287ch1q21.html |
Genes | SHC4 (SHC (Src homology 2 domain containing) family, member 4) | Pasini L, Lanfrancone L | http://atlasgeneticsoncology.org/Genes/SHC4ID44503ch15q21.html |
Genes | SLC5A5 (solute carrier family 5 (sodium iodide symporter), member 5) | Di Bernardo J, Rhoden KJ | http://atlasgeneticsoncology.org/Genes/SLC5A5ID44476ch19p13.html |
Genes | SLC5A8 (solute carrier family 5 member 8) | Di Bernardo J, Rhoden KJ | http://atlasgeneticsoncology.org/Genes/SLC5A8ID44089ch12q23.html |
Genes | SOX4 (SRY (sex determining region Y)-box 4) | Satinover DL, Moskaluk CA | http://atlasgeneticsoncology.org/Genes/SOX4ID42358ch6p22.html |
Genes | SPINT1 (serine peptidase inhibitor, Kunitz type 1) | Kataoka H | http://atlasgeneticsoncology.org/Genes/SPINT1ID44384ch15q15.html |
Genes | SRC (v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)) | Hiscox S | http://atlasgeneticsoncology.org/Genes/SRCID448ch20q11.html |
Genes | STEAP1 (Six Transmembrane Epithelial Antigene of the Prostate 1) | Santos C, Socorro S, Maia C | http://atlasgeneticsoncology.org/Genes/STEAP1ID44482ch7q21.html |
Genes | TAC1 (tachykinin, precursor 1) | Lim PK, Patel SA, Rameshwar P | http://atlasgeneticsoncology.org/Genes/TAC1ID44483ch7q21.html |
Genes | TACC3 (transforming, acidic coiled-coil containing protein 3) | Eslinger MR, Lauffart B, Still IH | http://atlasgeneticsoncology.org/Genes/TACC3ID42458ch4p16.html |
Genes | TEK (TEK tyrosine kinase, endothelial) | Liu D, Martin V, Gomez-Manzano C | http://atlasgeneticsoncology.org/Genes/TEKID42517ch9p21.html |
Genes | TFAP2A (transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)) | Orso F, Taverna D | http://atlasgeneticsoncology.org/Genes/TFAP2AID42526ch6p24.html |
Genes | TGFBI (transforming growth factor, beta-induced, 68kDa) | Ma C, Wang XF | http://atlasgeneticsoncology.org/Genes/TGFBIID42539ch5q31.html |
Genes | TJP2 (tight junction protein 2 (zona occludens 2)) | Gonzalez-Mariscal L, Garay E, Quiros M, Tapia R | http://atlasgeneticsoncology.org/Genes/TJP2ID44347ch9q21.html |
Genes | TMPRSS4 (transmembrane protease, serine 4) | Park Y | http://atlasgeneticsoncology.org/Genes/TMPRSS4ID42594ch11q23.html |
Genes | TNFAIP3 (tumor necrosis factor, alpha-induced protein 3) | Rasi S, Rossi D, Gaidano G | http://atlasgeneticsoncology.org/Genes/TNFAIP3ID42600ch6q23.html |
Genes | TNFSF15 (tumor necrosis factor (ligand) superfamily, member 15) | Yang GL, Qi JW, Zhang ZS, Li LY | http://atlasgeneticsoncology.org/Genes/TNFSF15ID42638ch9q32.html |
Genes | TOPORS (topoisomerase I binding, arginine/serine-rich) | Sharif J, Tsuboi A, Koseki H | http://atlasgeneticsoncology.org/Genes/TOPORSID42663ch9p21.html |
Genes | TP53INP1 (tumor protein p53 inducible nuclear protein 1) | Seux M, Carrier A, Iovanna J, Dusetti N | http://atlasgeneticsoncology.org/Genes/TP53INP1ID42672ch8q22.html |
Genes | TRPM1 (transient receptor potential cation channel, subfamily M, member 1) | Devi S, Setaluri V | http://atlasgeneticsoncology.org/Genes/TRPM1ID42707ch15q13.html |
Genes | TRPV6 (transient receptor potential cation channel, subfamily V, member 6) | Suzuki Y, Hediger MA | http://atlasgeneticsoncology.org/Genes/TRPV6ID44425ch7q34.html |
Genes | TSHR (thyroid stimulating hormone receptor) | Iosco C, Rhoden KJ | http://atlasgeneticsoncology.org/Genes/TSHRID290ch14q31.html |
Genes | TSPAN8 (tetraspanin 8) | Galli UM | http://atlasgeneticsoncology.org/Genes/TSPAN8ID42585ch12q21.html |
Genes | TWIST1 (twist homolog 1 (Drosophila)) | Valdés-Mora F, Gómez del Pulgar T, Lacal JC | http://atlasgeneticsoncology.org/Genes/TWIST1ID44296ch7p21.html |
Genes | TXN (thioredoxin) | Chen Z, Yoshihara E, Nakamura H, Masutani H, Yodoi J | http://atlasgeneticsoncology.org/Genes/TXNID44354ch9q31.html |
Leukemias | Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) | Cuneo A, Ciccone M, Cavazzini F, Rigolin GM | http://atlasgeneticsoncology.org/Anomalies/PeripheralTlymphoID2096.html |
Leukemias | del(5q) in myeloid neoplasms | Kanehira K, Ketterling RP, Van Dyke DL | http://atlasgeneticsoncology.org/Anomalies/del5qID1092.html |
Leukemias | dic(9;20)(p11-13;q11) PAX5/Various | Strefford JC | http://atlasgeneticsoncology.org/Anomalies/dic920ID1143.html |
Leukemias | inv(6)(p25q13) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/inv06p25q13ID1534.html |
Leukemias | t(11;11)(q13;q23) KMT2A/ARHGEF17 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1111q13q23ID1541.html |
Leukemias | t(11;14)(q23;q32) KMT2A/CEP170B | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1114q23q32ID1539.html |
Leukemias | t(11;16)(q23;p13.3) KMT2A/CREBBP | Labis E | http://atlasgeneticsoncology.org/Anomalies/t1116q23p13ID1120.html |
Leukemias | t(11;19)(q23;p13.3) KMT2A/ACER1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1119q23p13ID1540.html |
Leukemias | t(11;21)(q13;q22) RUNX1/MACROD1 | Huret JL, Xue Y | http://atlasgeneticsoncology.org/Anomalies/t1121q13q22ID1505.html |
Leukemias | t(12;19)(q13;q13) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1219q13q13ID1532.html |
Leukemias | t(17;17)(q21;q21) STAT5B/RARA | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1717q21q21ID1456.html |
Leukemias | t(1;12)(q21;q24) | Lee SG, Park TS, Choi JR | http://atlasgeneticsoncology.org/Anomalies/t0112q21q24ID1531.html |
Leukemias | t(1;14)(q21;q32) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0114q21q32ID1548.html |
Leukemias | t(1;21)(q12;q22) RUNX1/? | Xue Y, Huret JL. | http://atlasgeneticsoncology.org/Anomalies/t0121q12q22ID2135.html |
Leukemias | t(2;12)(p12;p13) IGK/CCND2 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t1214p13q32ID1487.html |
Leukemias | t(2;5)(p21;q33) SPTBN1/PDGFRB | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0205p21q33ID1511.html |
Leukemias | t(2;7)(p11;q21) IGK/CDK6 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0714q21q32ID1361.html |
Leukemias | t(3;11)(q29;p15) NUP98/IQCG | Chen L-T, Chen S-J | http://atlasgeneticsoncology.org/Anomalies/t0311q29p15ID1508.html |
Leukemias | t(3;3)(q27;q28) EIF4A2/BCL6 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0303q27q28ID2090.html |
Leukemias | t(3;3)(q27;q29) TFRC/BCL6 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0303q27q29ID2087.html |
Leukemias | t(3;6)(q27;p21) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0306q27p21ID2155.html |
Leukemias | t(3;6)(q27;p21) PIM1/BCL6 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0306q27p21ID2088.html |
Leukemias | t(3;6)(q27;p21) SRSF3/BCL6 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0306q27p21ID1336.html |
Leukemias | t(3;9)(q27;p24) DMRT1/BCL6 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0309q27p24ID1488.html |
Leukemias | t(4;5)(q21;q33) PRKG2/PDGFRB | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0405q21q33ID1510.html |
Leukemias | t(5;11)(q33;p13) CAPRIN1/PDGFRB | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0511q33p13ID1543.html |
Leukemias | t(5;12)(q33;q24) GIT2/PDGFRB | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0512q33q24ID1544.html |
Leukemias | t(5;14)(q35;q11) TRD/NKX2-5 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0514q35q11ID1385.html |
Leukemias | t(6;11)(q15;q23) KMT2A/? | Park TS, Choi JR | http://atlasgeneticsoncology.org/Anomalies/t0611q15q23ID1522.html |
Leukemias | t(7;14)(q21;q32) ERVW-1/IgH | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0714q21q32ID1346.html |
Leukemias | t(8;17)(q13;q23) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0817q13q23ID1403.html |
Leukemias | t(8;20)(p11;q13) KAT6A/NCOA3 | Mozziconacci MJ, Pérot C | http://atlasgeneticsoncology.org/Anomalies/t820p11q13ID1507.html |
Leukemias | t(8;9)(q24;q13) | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0809q24q13ID1550.html |
Solid Tumors | Bone: Osteoblastoma | de Andrea CE, Hogendoorn PCW | http://atlasgeneticsoncology.org/Anomalies/t0809q24q13ID1550.html |
Solid Tumors | Bone: Osteoid Osteoma | de Andrea CE, Hogendoorn PCW | http://atlasgeneticsoncology.org/Anomalies/t0809q24q13ID1550.html |
Solid Tumors | Bone: Osteoma | de Andrea CE, Hogendoorn PCW | http://atlasgeneticsoncology.org/Anomalies/t0809q24q13ID1550.html |
Solid Tumors | Esophagus: Barrett's esophagus, dysplasia and adenocarcinoma | Peng D, El-Rifai W | http://atlasgeneticsoncology.org/Anomalies/t0809q24q13ID1550.html |
Solid Tumors | Head and Neck: Ear: Endolymphatic Sac Tumor (ELST) | Diaz RC | http://atlasgeneticsoncology.org/Anomalies/t0809q24q13ID1550.html |
Solid Tumors | Head and Neck: Iris Hamartomas | Kiratli H | http://atlasgeneticsoncology.org/Anomalies/t0809q24q13ID1550.html |
Solid Tumors | Head and neck: Retinoblastoma | Kiratli H, Tarlan B | http://atlasgeneticsoncology.org/Anomalies/t0809q24q13ID1550.html |
Solid Tumors | Heart: Cardiac Myxoma | Raith EP | http://atlasgeneticsoncology.org/Anomalies/t0809q24q13ID1550.html |
Solid Tumors | Kidney: Mucinous tubular and spindle cell carcinoma | Yeh YA, Chan TY | http://atlasgeneticsoncology.org/Anomalies/t0809q24q13ID1550.html |
Solid Tumors | Ovary: Germ cell tumours with inv(10)(q11q11) RET/NCOA | Richardson DS, Mulligan LM | http://atlasgeneticsoncology.org/Anomalies/t0809q24q13ID1550.html |
Solid Tumors | Skin: Pilomatricoma | Angadi PV | http://atlasgeneticsoncology.org/Anomalies/t0809q24q13ID1550.html |
Solid Tumors | Soft Tissues: Alveolar rhabdomyosarcoma | Barr FG | http://atlasgeneticsoncology.org/Anomalies/t0809q24q13ID1550.html |
Solid Tumors | Soft Tissues: Angiomatoid fibrous histiocytoma with t(12;22)(q13;q12) EWSR1/ATF1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0809q24q13ID1550.html |
Solid Tumors | Soft Tissues: Angiomatoid fibrous histiocytoma with t(2;22)(q34;q12) EWSR1/CREB1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0809q24q13ID1550.html |
Solid Tumors | Soft Tissues: Embryonal rhabdomyosarcoma | Barr FG | http://atlasgeneticsoncology.org/Anomalies/t0809q24q13ID1550.html |
Solid Tumors | Soft Tissues: Embryonal rhabdomyosarcoma with t(4;22)(q35;q12) EWSR1/DUX4 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0809q24q13ID1550.html |
Solid Tumors | Soft Tissues: Lymphangioleiomyoma | Glasgow CG, Taveira-DaSilva AM, Moss J | http://atlasgeneticsoncology.org/Anomalies/t0809q24q13ID1550.html |
Solid Tumors | Soft Tissues: Myoepithelioma with t(1;22)(q23;q12) EWSR1/PBX1 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0809q24q13ID1550.html |
Solid Tumors | Soft Tissues: Rhabdomyosarcoma | Reichek J, Barr FG | http://atlasgeneticsoncology.org/Anomalies/t0809q24q13ID1550.html |
Solid Tumors | Soft Tissues: Small round cell tumour with t(2;22)(q31;q12) EWSR1/SP3 | Huret JL | http://atlasgeneticsoncology.org/Anomalies/t0809q24q13ID1550.html |
Cancer-Prones | Familial tylosis | Saraj O, Jankowski JA | http://atlasgeneticsoncology.org/Kprones/FamTylosisID10100.html |
Cancer-Prones | Hereditary diffuse gastric cancer (HDGC) | Saraj O, Jankowski JA | http://atlasgeneticsoncology.org/Kprones/HereditaryDiffuseGastricCarcID10078.html |
Deep Insights | Caspase-8 and Cancer | Fulda S | http://atlasgeneticsoncology.org/Deep/Casp8inCancerID20080.html |
Deep Insights | Detection of minimal residual disease in acute lymphoblastic leukemia | Campana D | http://atlasgeneticsoncology.org/Deep/MDRinALLID20063.html |
Deep Insights | Dynamics and plasticity of chromosome ends: consequences in human pathologies | Schluth-Bolard C, Ottaviani A, Bah A, Boussouar A, Gilson E, Magdinier F | http://atlasgeneticsoncology.org/Deep/SubTelomereID20025.html |
Deep Insights | Mapping of Structure-Function Peptide Sites on the Human Alpha-fetoprotein Amino Acid Sequence | Mizejewski GJ | http://atlasgeneticsoncology.org/Deep/MappingAFPID20077.html |
Deep Insights | RLN2 and its role in cancer | Willcox JM, Summerlee AJS | http://atlasgeneticsoncology.org/Deep/RLN2inCancerID20079.html |
Deep Insights | Role of TWIST proteins in cancer progression | Bastid J, Ciancia C, Puisieux A, Ansieau S | http://atlasgeneticsoncology.org/Deep/TWISTinCancerID20081.html |
Deep Insights | TGFβ and Bim: Partners in cell death | Wildey GM, Howe PH | http://atlasgeneticsoncology.org/Deep/TGFbBimID20082.html |
Deep Insights | The IKK-related kinases, unsuspected culprits in oncogenesis? | Servant MJ, Clément JF, Meloche S | http://atlasgeneticsoncology.org/Deep/IKKinOncoID20076.html |
Educational Items | Anomalies chromosomiques apparemment équilibrées et phénotype anormal | Rival JM | http://atlasgeneticsoncology.org/Educ/BalancedRearAbnorFrID30071FS.html |
Educational Items | Apparently balanced structural chromosome rearrangements (ABSCRs) and abnormal phenotype | Rival JM | http://atlasgeneticsoncology.org/Educ/BalancedRearAbnorID30071ES.html |